Contrasting Guardian Pharmacy Services (GRDN) and Its Peers

Guardian Pharmacy Services (NYSE:GRDN) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it contrast to its competitors? We will compare Guardian Pharmacy Services to related companies based on the strength of its profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation.

Analyst Recommendations

This is a summary of current ratings and target prices for Guardian Pharmacy Services and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0	1	9	0	2.90
Guardian Pharmacy Services Competitors	1839	7695	13234	814	2.55

Guardian Pharmacy Services currently has a consensus price target of $45.57, indicating a potential upside of 12.19%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.96%. Given Guardian Pharmacy Services’ competitors higher probable upside, analysts plainly believe Guardian Pharmacy Services has less favorable growth aspects than its competitors.

Institutional and Insider Ownership

56.8% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 33.0% of Guardian Pharmacy Services shares are held by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Guardian Pharmacy Services and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Guardian Pharmacy Services	$1.46 billion	$49.22 million	39.44
Guardian Pharmacy Services Competitors	$18.98 billion	$288.48 million	7.10

Guardian Pharmacy Services’ competitors have higher revenue and earnings than Guardian Pharmacy Services. Guardian Pharmacy Services is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

Guardian Pharmacy Services has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Comparatively, Guardian Pharmacy Services’ competitors have a beta of 0.96, meaning that their average stock price is 4% less volatile than the S&P 500.

Profitability

This table compares Guardian Pharmacy Services and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Guardian Pharmacy Services Competitors	-7.78%	-141.21%	-1.54%

Summary

Guardian Pharmacy Services beats its competitors on 7 of the 13 factors compared.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.